Add like
Add dislike
Add to saved papers

Mechanism of T H 2/T H 17-predominant and neutrophilic T H 2/T H 17-low subtypes of asthma.

BACKGROUND: The mechanism of TH 2/TH 17-predominant and TH 2/TH 17-low asthma is unknown.

OBJECTIVE: We sought to study the immune mechanism of TH 2/TH 17-predominant and TH 2/TH 17-low asthma.

METHODS: In a previously reported cohort of 60 asthmatic patients, 16 patients were immunophenotyped with TH 2/TH 17-predominant asthma and 22 patients with TH 2/TH 17-low asthma. We examined bronchoalveolar lavage (BAL) fluid leukocytes, cytokines, mediators, and epithelial cell function for these asthma subgroups.

RESULTS: Patients with TH 2/TH 17-predominant asthma had increased IL-1β, IL-6, IL-23, C3a, and serum amyloid A levels in BAL fluid, and these correlated with IL-1β and C3a levels. TH 2/TH 17 cells expressed higher levels of the IL-1 receptor and phospho-p38 mitogen-activated protein kinase. Anakinra, an IL-1 receptor antagonist protein, inhibited BAL TH 2/TH 17 cell counts. TH 2/TH 17-low asthma had 2 distinct subgroups: neutrophilic asthma (45%) and pauci-inflammatory asthma (55%). This contrasted with patients with TH 2/TH 17-predominant and TH 2-predominant asthma, which included neutrophilic asthma in 6% and 0% of patients, respectively. BAL fluid neutrophils strongly correlated with BAL fluid myeloperoxidase, IL-8, IL-1α, IL-6, granulocyte colony-stimulating factor, and GM-CSF levels. Sixty percent of the patients with neutrophilic asthma had a pathogenic microorganism in BAL culture, which suggested a subclinical infection.

CONCLUSION: We uncovered a critical role for the IL-1β pathway in patients with TH 2/TH 17-predminant asthma. A subgroup of patients with TH 2/TH 17-low asthma had neutrophilic asthma and increased BAL fluid IL-1α, IL-6, IL-8, granulocyte colony-stimulating factor, and GM-CSF levels. IL-1α was directly involved in IL-8 production and likely contributed to neutrophilic asthma. Sixty percent of neutrophilic patients had a subclinical infection.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app